These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. Gravholt CH; Christian Klausen I; Weeke J; Sandahl Christiansen J Atherosclerosis; 2000 May; 150(1):201-8. PubMed ID: 10781652 [TBL] [Abstract][Full Text] [Related]
24. Effects of amiodarone, sematilide, and sotalol on QT dispersion. Cui G; Sen L; Sager P; Uppal P; Singh BN Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675 [TBL] [Abstract][Full Text] [Related]
25. QT interval prolongation associated with amiodarone use in Cipto Mangunkusumo Hospital, Jakarta. Nafrialdi ; Kurniawan TG; Setiawati A; Makmun LH Acta Med Indones; 2014 Oct; 46(4):292-7. PubMed ID: 25633545 [TBL] [Abstract][Full Text] [Related]
26. Autoimmune diseases in women with Turner's syndrome. Jørgensen KT; Rostgaard K; Bache I; Biggar RJ; Nielsen NM; Tommerup N; Frisch M Arthritis Rheum; 2010 Mar; 62(3):658-66. PubMed ID: 20187158 [TBL] [Abstract][Full Text] [Related]
27. Drugs and ventricular repolarization in a general population: the Rotterdam Study. Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883 [TBL] [Abstract][Full Text] [Related]
28. No Untoward Effect of Long-Term Ketoconazole Administration on Electrocardiographic QT Interval in Patients with Cushing's Disease. De Martin M; Toja PM; Goulene K; Radaelli P; Cavagnini F; Stramba-Badiale M; Pecori Giraldi F Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):279-83. PubMed ID: 26386326 [TBL] [Abstract][Full Text] [Related]
29. Effects of concomitant amiodarone and haloperidol on Q-Tc interval prolongation. Bush SE; Hatton RC; Winterstein AG; Thomson MR; Woo GW Am J Health Syst Pharm; 2008 Dec; 65(23):2232-6. PubMed ID: 19020191 [TBL] [Abstract][Full Text] [Related]
30. Phenotype of Children with QT Prolongation Identified Using an Institution-Wide QT Alert System. Anderson HN; Bos JM; Haugaa KH; Morlan BW; Tarrell RF; Caraballo PJ; Ackerman MJ Pediatr Cardiol; 2015 Oct; 36(7):1350-6. PubMed ID: 25845942 [TBL] [Abstract][Full Text] [Related]
31. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938 [TBL] [Abstract][Full Text] [Related]
32. Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone. Fei L; Slade AK; Grace AA; Malik M; Camm AJ; McKenna WJ Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2222-7. PubMed ID: 7845847 [TBL] [Abstract][Full Text] [Related]
33. Pregnancies in women with Turner's syndrome. Hovatta O Ann Med; 1999 Apr; 31(2):106-10. PubMed ID: 10344582 [TBL] [Abstract][Full Text] [Related]
34. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Mayet S; Gossop M; Lintzeris N; Markides V; Strang J Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918 [TBL] [Abstract][Full Text] [Related]
35. Normal DXA bone mineral density but frail cortical bone in Turner's syndrome. Zuckerman-Levin N; Yaniv I; Schwartz T; Guttmann H; Hochberg Z Clin Endocrinol (Oxf); 2007 Jul; 67(1):60-4. PubMed ID: 17437508 [TBL] [Abstract][Full Text] [Related]
36. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596 [TBL] [Abstract][Full Text] [Related]
37. Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women. Salem JE; Dureau P; Bachelot A; Germain M; Voiriot P; Lebourgeois B; Trégouët DA; Hulot JS; Funck-Brentano C JAMA Cardiol; 2018 Sep; 3(9):877-882. PubMed ID: 30073300 [TBL] [Abstract][Full Text] [Related]
38. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation. Milic M; Bao X; Rizos D; Liu F; Ziegler MG Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469 [TBL] [Abstract][Full Text] [Related]
39. Sevoflurane prolonged the QTc interval and increased transmural dispersion of repolarization in a patient with long QT syndrome 3: a case report. Kitaura A; Nakao S; Hamasaki S; Houri K; Tsujimoto T; Kimura S; Matsushima M JA Clin Rep; 2017; 3(1):29. PubMed ID: 29457073 [TBL] [Abstract][Full Text] [Related]
40. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Tisdale JE Can Pharm J (Ott); 2016 May; 149(3):139-52. PubMed ID: 27212965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]